New research reveals 57% of U.S. adults regularly consume foods that fuel inflammation, increasing risks of chronic diseases.

An international team of researchers has explored how multi-omics—the integration of molecular data across different ...

Political and business leaders are rethinking AI—as not just a technology to regulate but as a force to accelerate. Medicine ...

America’s chronic disease crisis—a problem Secretary Kennedy and the Make America Healthy Again (MAHA) brigade, armed with ...

Mass. health officials said the state is seeing a “possible increase” in children having neurological complications ...

President Donald Trump issued an executive order last week for a team to study the use of antidepressants in children.

Zing Health plans to beef up its value-base care, or VBC, business for members with chronic cardiac care needs through an ...

Dr Amir Khan said he had been asked to speak out about the condition - which can often cause a 'red flag' symptom ...

A headache lasting more than 72 hours must be addressed in the emergency room or with a doctor. Here's why it happens and the ...

YESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.

Louisiana inmate Christopher Sepulvado died Saturday, just over three weeks before he was scheduled to be put to death for ...

Biocon added 1.36% to Rs 325.25 after the company announced that its subsidiary, Biocon Biologics (BBL), has launched YESINTEK (ustekinumab-kfce) in the United States.